Literature DB >> 32841759

The splice 1 variant of HTLV-1 bZIP factor stabilizes c-Jun.

Nicholas Polakowski1, Martin Pearce2, Oppah Kuguyo2, Georgina Boateng2, Kimson Hoang2, Isabelle Lemasson3.   

Abstract

HBZ is expressed by the complex retrovirus, Human T-cell Leukemia Virus type 1, and implicated in pathological effects associated with viral infection. From the nucleus, HBZ alters gene expression by interacting with a variety of transcriptional regulatory proteins, among which is c-Jun. Previously, one of the three HBZ variants, HBZUS, was reported to decrease c-Jun expression by promoting its degradation. Here we show that another variant, HBZS1, produces the opposite effect. In the presence of HBZS1, c-Jun expression increases due to its stabilization. Our data suggest that this effect requires the ability of HBZS1 to interact with c-Jun. We provide evidence that HBZS1 inhibits the proteosomal degradation of c-Jun initiated by the Cop1-containing ubiquitin ligase complex. HBZS1 is the most abundant variant in HTLV-1-infected T-cells, and our data indicate that levels of c-Jun expression in infected cells are consistent with effects of HBZS1.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cop1; HBZ splice 1 variant; HTLV-1; c-Jun

Mesh:

Substances:

Year:  2020        PMID: 32841759      PMCID: PMC7528937          DOI: 10.1016/j.virol.2020.07.013

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  50 in total

1.  The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells.

Authors:  R Pozzatti; J Vogel; G Jay
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

2.  HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation.

Authors:  Kenji Sugata; Jun-Ichirou Yasunaga; Haruka Kinosada; Yuichi Mitobe; Rie Furuta; Mohamed Mahgoub; Chiho Onishi; Kazutaka Nakashima; Koichi Ohshima; Masao Matsuoka
Journal:  Cancer Res       Date:  2016-07-11       Impact factor: 12.701

3.  Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia.

Authors:  S Tamiya; M Matsuoka; K Etoh; T Watanabe; S Kamihira; K Yamaguchi; K Takatsuki
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

4.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain.

Authors:  M Treier; L M Staszewski; D Bohmann
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

5.  The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription.

Authors:  Gilles Gaudray; Frederic Gachon; Jihane Basbous; Martine Biard-Piechaczyk; Christian Devaux; Jean-Michel Mesnard
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch.

Authors:  Min Gao; Tord Labuda; Ying Xia; Ewen Gallagher; Deyu Fang; Yun-Cai Liu; Michael Karin
Journal:  Science       Date:  2004-09-09       Impact factor: 47.728

Review 7.  AP-1--The Jun proteins: Oncogenes or tumor suppressors in disguise?

Authors:  Eitan Shaulian
Journal:  Cell Signal       Date:  2010-01-11       Impact factor: 4.315

8.  Induction of proto-oncogene JUN/AP-1 by serum and TPA.

Authors:  W W Lamph; P Wamsley; P Sassone-Corsi; I M Verma
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

9.  Non-canonical translation initiation of the spliced mRNA encoding the human T-cell leukemia virus type 1 basic leucine zipper protein.

Authors:  C Joaquín Cáceres; Jenniffer Angulo; Fernando Lowy; Nataly Contreras; Beth Walters; Eduardo Olivares; Delphine Allouche; Anne Merviel; Karla Pino; Bruno Sargueil; Sunnie R Thompson; Marcelo López-Lastra
Journal:  Nucleic Acids Res       Date:  2018-11-16       Impact factor: 16.971

Review 10.  HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia-Lymphoma.

Authors:  Makoto Yamagishi; Dai Fujikawa; Toshiki Watanabe; Kaoru Uchimaru
Journal:  Front Microbiol       Date:  2018-07-24       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.